Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02946801Phase 4
Key facts
Phase 4, randomised trial of Listerine Zero in gingivitis, sponsored by Universidad de Santiago de Compostela. Primary endpoint: Percentage of bacterial viability at 96 hours. Status: unknown.
Systemically healthy adults with at least 24 permanent teeth and no signs of gingivitis, periodontitis, or untreated caries. Excludes smokers, former smokers, and individuals with dental prostheses or orthodontic devices.
Percentage of bacterial viability
Beyond the preview
Full results, competitive context and analysis are in the Gosset platform.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02946801.